SCHEMBL30424151

SCHEMBL30424151

NC(=O)c1sccc1-c1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.58
IKBKB O14920 2/20 0.48
TGFBR1 P36897 2/20 0.44
LIMK1 P53667 2/20 0.42
CHUK O15111 1/20 0.42
ADORA1 P30542 1/20 0.42
GRM5 P41594 1/20 0.42
ALOX5 P09917 1/20 0.41
CHEK2 O96017 1/20 0.41
KDM4E B2RXH2 4/20 0.41
LMNA P02545 2/20 0.41
METAP1 P53582 2/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CCR1 P32246 1/20 0.41
CCR5 P51681 1/20 0.41
CCR8 P51685 1/20 0.41
BLM P54132 1/20 0.41
HIF1A Q16665 1/20 0.41
DOHH Q9BU89 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1379791 1.00 BCAT2 (0.58) BCAT2IKBKBTGFBR1LIMK1CHUK
SCHEMBL3599161 0.85 KDM4E (0.50) BCAT2KDM4ELMNAMETAP1CYP1A2
SCHEMBL16011605 0.81 BCAT2 (0.59) BCAT2IKBKBLIMK1CHUKCHEK2
SCHEMBL6530008 0.81 HDAC3 (0.54) KDM4ELMNAMETAP1POLBKMT2A
SCHEMBL27711486 0.79 BCAT2 (0.49) BCAT2IKBKBLIMK1CHUKADORA1
SCHEMBL31281737 0.77 CHEK2 (0.41) BCAT2IKBKBTGFBR1ADORA1GRM5
SCHEMBL31661830 0.75 MKNK1 (0.54) BCAT2IKBKBLIMK1CHUKKDM4E
SCHEMBL1430238 0.75 KDM4E (0.54) IKBKBTGFBR1GRM5CHEK2KDM4E
SCHEMBL28555658 0.75 GRM5 (0.52) BCAT2TGFBR1GRM5CHEK2KDM4E
SCHEMBL29996179 0.74 BCAT2 (0.50) BCAT2IKBKBLIMK1CHUKCHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151311-A1 NICOTINAMIDE DERIVATIVES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-07-17 WO disclosed
EP-4479138-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 EP disclosed
WO-2023154519-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-17 WO disclosed
CN-116143763-A GAS41 targeting compound, GAS41 inhibitor and pharmaceutical composition and application thereof 清华大学 2023-05-23 CN disclosed